Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

doi:10.3390/cancers15245762

. 2023 Dec 8;15(24):5762.

doi: 10.3390/cancers15245762.

Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Pavlina Chrysafi^{1

2}, Chinmay T Jani^{1

2

3}, Margaret Lotz^{1

4}, Omar Al Omari⁵, Harpreet Singh⁶, Katherine Stafford^{1

2}, Lipisha Agarwal⁷, Arashdeep Rupal⁸, Abdul Qadir Dar⁹, Abby Dangelo^{1

4}, Prudence Lam^{1

2}

Affiliations

¹ Department of Medicine, Mount Auburn Hospital, Cambridge, MA 02138, USA.
² Department of Medicine, Harvard Medical School, Boston, MA 02129, USA.
³ Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33146, USA.
⁴ Division of Hematology and Oncology, Mount Auburn Hospital, Cambridge, MA 02138, USA.
⁵ Department of Pulmonary and Critical Care, Temple University, Philadelphia, PA 19122, USA.
⁶ Department of Pulmonary and Critical Care, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
⁷ Department of Pulmonary and Critical Care, University of Vermont, Burlington, VT 05405, USA.
⁸ Department of Pulmonary and Critical Care, University of South Florida, Tampa, FL 33620, USA.
⁹ Department of Medicine, Lahey Medical Center, Burlington, MA 01805, USA.

PMID: 38136308
PMCID: PMC10742236
DOI: 10.3390/cancers15245762

Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Pavlina Chrysafi et al. Cancers (Basel). 2023.

. 2023 Dec 8;15(24):5762.

doi: 10.3390/cancers15245762.

Authors

Affiliations

¹ Department of Medicine, Mount Auburn Hospital, Cambridge, MA 02138, USA.
² Department of Medicine, Harvard Medical School, Boston, MA 02129, USA.
³ Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33146, USA.
⁴ Division of Hematology and Oncology, Mount Auburn Hospital, Cambridge, MA 02138, USA.
⁵ Department of Pulmonary and Critical Care, Temple University, Philadelphia, PA 19122, USA.
⁶ Department of Pulmonary and Critical Care, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
⁷ Department of Pulmonary and Critical Care, University of Vermont, Burlington, VT 05405, USA.
⁸ Department of Pulmonary and Critical Care, University of South Florida, Tampa, FL 33620, USA.
⁹ Department of Medicine, Lahey Medical Center, Burlington, MA 01805, USA.

PMID: 38136308
PMCID: PMC10742236
DOI: 10.3390/cancers15245762

Abstract

Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome (LS) are the most common inherited cancer syndromes identified with genetic testing. Testing, though, commonly reveals variants of uncertain significance (VUSs). This is a retrospective observational study designed to determine the prevalence of pathogenic mutations and VUSs in patients tested for HBOC and/or LS and to explore the characteristics of the VUS population. Patients 18-80 years old that met NCCN criteria for HBOC and/or LS genetic screening were tested between 2006 and 2020 at Mount Auburn Hospital in Cambridge, Massachusetts. A total of 663 patients were included in the study, with a mean age of 50 years old and 90% being females. Pathogenic mutations were identified in 12.5% and VUSs in 28.3%. VUS prevalence was associated with race (p-value = 0.019), being particularly higher in Asian populations. Patients with a personal history of breast cancer or family history of breast or ovarian cancer were more likely to have a VUS (personal breast: OR: 1.55; CI: 1.08-2.25; family breast: OR: 1.68; CI: 1.08-2.60, family ovarian OR: 2.29; CI: 1.04-5.45). In conclusion, VUSs appear to be detected in almost one third patients tested for cancer genetic syndromes, and thus future work is warranted to determine their significance in cancer development.

Keywords: HBOC; Lynch syndrome; genetic screening; variant of uncertain significance (VUS).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

**Figure 1**
Most common genes in which VUSs were detected.

See this image and copyright information in PMC

Cited by

Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.
Fernández Aceñero MJ, Díaz Del Arco C. Fernández Aceñero MJ, et al. Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385. Curr Issues Mol Biol. 2024. PMID: 39057027 Free PMC article. Review.
The Role of Health Literacy in Skin Cancer Preventative Behavior and Implications for Intervention: A Systematic Review.
Chang RC, Yen H, Heskett KM, Yen H. Chang RC, et al. J Prev (2022). 2024 Dec;45(6):957-972. doi: 10.1007/s10935-024-00795-x. Epub 2024 Aug 7. J Prev (2022). 2024. PMID: 39110380 Review.

References

1. Federici G., Soddu S. Variants of uncertain significance in the era of high-throughput genome sequencing: A lesson from breast and ovary cancers. J. Exp. Clin. Cancer Res. 2020;39:46. doi: 10.1186/s13046-020-01554-6. - DOI - PMC - PubMed
1. Yohe S., Thyagarajan B. Review of Clinical Next-Generation Sequencing. Arch. Pathol. Lab. Med. 2017;141:1544–1557. doi: 10.5858/arpa.2016-0501-RA. - DOI - PubMed
1. Burke W., Parens E., Chung W.K., Berger S.M., Appelbaum P.S. The Challenge of Genetic Variants of Uncertain Clinical Significance: A Narrative Review. Ann. Intern. Med. 2022;175:994–1000. doi: 10.7326/M21-4109. - DOI - PMC - PubMed
1. Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. - DOI - PMC - PubMed
1. Rahner N., Steinke V. Hereditary cancer syndromes. Dtsch. Arztebl. Int. 2008;105:706–714. doi: 10.3238/arztebl.2008.0706. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

[1] Federici G., Soddu S. Variants of uncertain significance in the era of high-throughput genome sequencing: A lesson from breast and ovary cancers. J. Exp. Clin. Cancer Res. 2020;39:46. doi: 10.1186/s13046-020-01554-6. - DOI - PMC - PubMed

[2] Federici G., Soddu S. Variants of uncertain significance in the era of high-throughput genome sequencing: A lesson from breast and ovary cancers. J. Exp. Clin. Cancer Res. 2020;39:46. doi: 10.1186/s13046-020-01554-6. - DOI - PMC - PubMed

[3] Yohe S., Thyagarajan B. Review of Clinical Next-Generation Sequencing. Arch. Pathol. Lab. Med. 2017;141:1544–1557. doi: 10.5858/arpa.2016-0501-RA. - DOI - PubMed

[4] Yohe S., Thyagarajan B. Review of Clinical Next-Generation Sequencing. Arch. Pathol. Lab. Med. 2017;141:1544–1557. doi: 10.5858/arpa.2016-0501-RA. - DOI - PubMed

[5] Burke W., Parens E., Chung W.K., Berger S.M., Appelbaum P.S. The Challenge of Genetic Variants of Uncertain Clinical Significance: A Narrative Review. Ann. Intern. Med. 2022;175:994–1000. doi: 10.7326/M21-4109. - DOI - PMC - PubMed

[6] Burke W., Parens E., Chung W.K., Berger S.M., Appelbaum P.S. The Challenge of Genetic Variants of Uncertain Clinical Significance: A Narrative Review. Ann. Intern. Med. 2022;175:994–1000. doi: 10.7326/M21-4109. - DOI - PMC - PubMed

[7] Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. - DOI - PMC - PubMed

[8] Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. - DOI - PMC - PubMed

[9] Rahner N., Steinke V. Hereditary cancer syndromes. Dtsch. Arztebl. Int. 2008;105:706–714. doi: 10.3238/arztebl.2008.0706. - DOI - PMC - PubMed

[10] Rahner N., Steinke V. Hereditary cancer syndromes. Dtsch. Arztebl. Int. 2008;105:706–714. doi: 10.3238/arztebl.2008.0706. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Affiliations

Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Miscellaneous